The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Survival trends and patterns of chemotherapy use in elderly metastatic colorectal cancer (mCRC) patients.
V. Shankaran
Research Funding - Genentech
S. J. Beck
No relevant relationships to disclose
D. K. Blough
No relevant relationships to disclose
L. Koepl
No relevant relationships to disclose
Y. M. Yim
Employment or Leadership Position - Genentech
Stock Ownership - Roche
E. Yu
Employment or Leadership Position - Genentech
Stock Ownership - Roche
S. D. Ramsey
No relevant relationships to disclose